Paul Tudor Jones’s Alder Biopharmaceuticals ALDR Stock Holding History

Paul Tudor Jones’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,503,000	Closed	-$28.3M	–	1498
2019 Q3	$28.3M	Buy	+1,503,000	New	+$17.2M	0.97%	10

Paul Tudor Jones's ALDR Position: Q4 2019 in Review

Paul Tudor Jones sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,115,371 shares — an estimated $21M sold.

Paul Tudor Jones first reported a position in ALDR in Q1 2015 and held it in 10 quarters. The position peaked at $21M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Paul Tudor Jones reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Paul Tudor Jones sold 1,115,371 Alder Biopharmaceuticals shares in Q4 2019, an estimated $21M.
Paul Tudor Jones first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 10 quarters.
Paul Tudor Jones's Alder Biopharmaceuticals position peaked at $21M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Tudor Investment Corp's 13F filing for Q4 2019, filed 14 Feb 2020.